gvtcx

supplier

Shire Pharmaceuticals Ltd

W26BD combined from 2 published records

as a supplier

17 recorded awards from 3 buyers , between 19 Jun 2018 and 2 Jun 2020.

awards won
17
exclusive
12%
2 sole-winner awards
median award
·
no comparable value
largest
·
no comparable value

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

No median is shown because every award here carries a framework ceiling rather than a settled price. A ceiling is the most that could be spent across every supplier on the agreement, so averaging them would overstate this organisation’s work, often by an order of magnitude. The individual values are listed below as published.

sells to

contracts won

contractbuyervalueawarded
NHS National Framework Agreement for the supply of products for the treatment of Haemophilia A shared NHS England £334,400,000 2 Jun 2020
NHS National Framework Agreement for the Supply of Lanadelumab NHS England £4,844,000 18 Dec 2019
NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B shared NHS England £192,000,000 15 Feb 2019
NHS Framework Agreement for the supply of Recombinant Factor IX products for the treatment of Haemophilia B shared NHS England £192,000,000 15 Feb 2019
NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema shared NHS England £72,000,000 19 Jun 2018
NHS National Framework agreement for the supply of Homecare Delivery Service - Products for the treatment of bleeding disorders in England, Wales and Northern Ireland shared NHS England £8,000,000 19 Jun 2018
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin shared NHS England · 16 Dec 2024
Medicinal Products and Pharma Funded Homecare Services shared Procurement and Logistics Service · 23 Jul 2021
Medicinal Products and Pharma Funded Homecare Services shared Procurement and Logistics Service · 23 Jul 2021
NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor The NHS Commissioning Board (operating under the name of NHS England) · 27 Jan 2021

every contract won by Shire Pharmaceuticals Ltd →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Shire Pharmaceuticals Ltd · W2 6BD 15
Shire Pharmaceuticals Limited GB-COH 02031674 · 2

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works